Hikma Pharmaceuticals Announces Director/PDMR Shareholding
Why we think this is neutral
This RNS announcement is related to a director/PDMR shareholding change, which is a routine regulatory disclosure and does not contain any significant business updates or financial information.
Key Points
- PDMR Dr Bill Larkins has disposed of 5,257 Hikma Pharmaceuticals shares at £21.28 per share
Summary
The pharmaceutical company has disclosed a transaction by a Person Discharging Managerial Responsibilities.
Hikma Pharmaceuticals PLC (LSE: HIK) has announced a transaction by a Person Discharging Managerial Responsibilities (PDMR) of the company. The PDMR, Dr Bill Larkins, has disposed of 5,257 ordinary shares in Hikma Pharmaceuticals PLC at a price of £21.28 per share.
DIRECTOR DEALINGS